nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—type 2 diabetes mellitus	0.292	1	CbGaD
Gatifloxacin—ALB—Gliclazide—type 2 diabetes mellitus	0.0978	0.204	CbGbCtD
Gatifloxacin—ALB—Repaglinide—type 2 diabetes mellitus	0.092	0.192	CbGbCtD
Gatifloxacin—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0768	0.16	CbGbCtD
Gatifloxacin—ALB—Valsartan—type 2 diabetes mellitus	0.0678	0.142	CbGbCtD
Gatifloxacin—ALB—Nateglinide—type 2 diabetes mellitus	0.063	0.132	CbGbCtD
Gatifloxacin—ALB—Glyburide—type 2 diabetes mellitus	0.0426	0.0889	CbGbCtD
Gatifloxacin—ALB—Losartan—type 2 diabetes mellitus	0.0389	0.0813	CbGbCtD
Gatifloxacin—Sparfloxacin—ABCC2—type 2 diabetes mellitus	0.000494	0.139	CrCbGaD
Gatifloxacin—Lomefloxacin—ABCC2—type 2 diabetes mellitus	0.000407	0.114	CrCbGaD
Gatifloxacin—Pefloxacin—CYP1A2—type 2 diabetes mellitus	0.000383	0.107	CrCbGaD
Gatifloxacin—Enoxacin—CYP1A2—type 2 diabetes mellitus	0.000359	0.101	CrCbGaD
Gatifloxacin—Ofloxacin—ABCC2—type 2 diabetes mellitus	0.000348	0.0975	CrCbGaD
Gatifloxacin—Lomefloxacin—CYP1A2—type 2 diabetes mellitus	0.000272	0.0762	CrCbGaD
Gatifloxacin—Ofloxacin—CYP1A2—type 2 diabetes mellitus	0.000232	0.0651	CrCbGaD
Gatifloxacin—Levofloxacin—CYP1A2—type 2 diabetes mellitus	0.000232	0.0651	CrCbGaD
Gatifloxacin—Ciprofloxacin—CYP1A2—type 2 diabetes mellitus	0.000224	0.0629	CrCbGaD
Gatifloxacin—Norfloxacin—CYP1A2—type 2 diabetes mellitus	0.000188	0.0528	CrCbGaD
Gatifloxacin—Levofloxacin—CYP3A4—type 2 diabetes mellitus	0.000154	0.0431	CrCbGaD
Gatifloxacin—Ciprofloxacin—CYP3A4—type 2 diabetes mellitus	0.000149	0.0416	CrCbGaD
Gatifloxacin—Norfloxacin—CYP3A4—type 2 diabetes mellitus	0.000125	0.035	CrCbGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	0.000122	0.00275	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—CRP—type 2 diabetes mellitus	0.000122	0.00275	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00012	0.0027	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000119	0.00269	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	0.000118	0.00267	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—APOA1—type 2 diabetes mellitus	0.000118	0.00266	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—CD36—type 2 diabetes mellitus	0.000116	0.00261	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	0.000115	0.0026	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—SERPINE1—type 2 diabetes mellitus	0.000115	0.00259	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—ICAM1—type 2 diabetes mellitus	0.000112	0.00252	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GRB14—type 2 diabetes mellitus	0.00011	0.0025	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—CD36—type 2 diabetes mellitus	0.00011	0.00249	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	0.00011	0.00248	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—RELA—type 2 diabetes mellitus	0.000103	0.00233	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—CALM1—type 2 diabetes mellitus	0.000102	0.00231	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—INS—type 2 diabetes mellitus	0.000102	0.0023	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	0.000102	0.00229	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000101	0.00229	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—APOA1—type 2 diabetes mellitus	0.000101	0.00228	CbGpPWpGaD
Gatifloxacin—Myalgia—Metformin—type 2 diabetes mellitus	0.000101	0.000557	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000101	0.00227	CbGpPWpGaD
Gatifloxacin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.0001	0.000555	CcSEcCtD
Gatifloxacin—Headache—Pioglitazone—type 2 diabetes mellitus	0.0001	0.000554	CcSEcCtD
Gatifloxacin—Syncope—Irbesartan—type 2 diabetes mellitus	0.0001	0.000554	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—CCL2—type 2 diabetes mellitus	0.0001	0.00226	CbGpPWpGaD
Gatifloxacin—Visual impairment—Ramipril—type 2 diabetes mellitus	9.98e-05	0.000552	CcSEcCtD
Gatifloxacin—Nausea—Glipizide—type 2 diabetes mellitus	9.92e-05	0.000549	CcSEcCtD
Gatifloxacin—Vomiting—Glimepiride—type 2 diabetes mellitus	9.91e-05	0.000548	CcSEcCtD
Gatifloxacin—Hypotension—Valsartan—type 2 diabetes mellitus	9.91e-05	0.000548	CcSEcCtD
Gatifloxacin—Vision blurred—Losartan—type 2 diabetes mellitus	9.91e-05	0.000548	CcSEcCtD
Gatifloxacin—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.88e-05	0.000546	CcSEcCtD
Gatifloxacin—Constipation—Gliclazide—type 2 diabetes mellitus	9.87e-05	0.000546	CcSEcCtD
Gatifloxacin—Tremor—Losartan—type 2 diabetes mellitus	9.85e-05	0.000544	CcSEcCtD
Gatifloxacin—Rash—Glimepiride—type 2 diabetes mellitus	9.83e-05	0.000543	CcSEcCtD
Gatifloxacin—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.82e-05	0.000543	CcSEcCtD
Gatifloxacin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.000543	CcSEcCtD
Gatifloxacin—Rash—Sitagliptin—type 2 diabetes mellitus	9.8e-05	0.000542	CcSEcCtD
Gatifloxacin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.79e-05	0.000541	CcSEcCtD
Gatifloxacin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000541	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	9.78e-05	0.00221	CbGpPWpGaD
Gatifloxacin—Headache—Glimepiride—type 2 diabetes mellitus	9.77e-05	0.00054	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—CALM1—type 2 diabetes mellitus	9.75e-05	0.0022	CbGpPWpGaD
Gatifloxacin—Headache—Sitagliptin—type 2 diabetes mellitus	9.74e-05	0.000538	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.66e-05	0.000534	CcSEcCtD
Gatifloxacin—Agitation—Losartan—type 2 diabetes mellitus	9.66e-05	0.000534	CcSEcCtD
Gatifloxacin—Oedema—Metformin—type 2 diabetes mellitus	9.66e-05	0.000534	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	9.66e-05	0.00218	CbGpPWpGaD
Gatifloxacin—Tinnitus—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000534	CcSEcCtD
Gatifloxacin—Hypertension—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000533	CcSEcCtD
Gatifloxacin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.62e-05	0.000532	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—type 2 diabetes mellitus	9.6e-05	0.00217	CbGpPWpGaD
Gatifloxacin—Angioedema—Losartan—type 2 diabetes mellitus	9.6e-05	0.000531	CcSEcCtD
Gatifloxacin—Infection—Metformin—type 2 diabetes mellitus	9.6e-05	0.00053	CcSEcCtD
Gatifloxacin—Insomnia—Valsartan—type 2 diabetes mellitus	9.59e-05	0.00053	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.55e-05	0.000528	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	9.53e-05	0.00215	CbGpPWpGaD
Gatifloxacin—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.52e-05	0.000527	CcSEcCtD
Gatifloxacin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.51e-05	0.000526	CcSEcCtD
Gatifloxacin—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000526	CcSEcCtD
Gatifloxacin—Chest pain—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000526	CcSEcCtD
Gatifloxacin—Myalgia—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000526	CcSEcCtD
Gatifloxacin—Shock—Metformin—type 2 diabetes mellitus	9.5e-05	0.000525	CcSEcCtD
Gatifloxacin—Insomnia—Orlistat—type 2 diabetes mellitus	9.48e-05	0.000524	CcSEcCtD
Gatifloxacin—Anxiety—Irbesartan—type 2 diabetes mellitus	9.48e-05	0.000524	CcSEcCtD
Gatifloxacin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.47e-05	0.000524	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.46e-05	0.000523	CcSEcCtD
Gatifloxacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.46e-05	0.000523	CcSEcCtD
Gatifloxacin—Vertigo—Losartan—type 2 diabetes mellitus	9.44e-05	0.000522	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.44e-05	0.000522	CcSEcCtD
Gatifloxacin—Somnolence—Valsartan—type 2 diabetes mellitus	9.43e-05	0.000521	CcSEcCtD
Gatifloxacin—Syncope—Losartan—type 2 diabetes mellitus	9.43e-05	0.000521	CcSEcCtD
Gatifloxacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.41e-05	0.00052	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	9.34e-05	0.00211	CbGpPWpGaD
Gatifloxacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.34e-05	0.000516	CcSEcCtD
Gatifloxacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.34e-05	0.000516	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—SERPINE1—type 2 diabetes mellitus	9.33e-05	0.00211	CbGpPWpGaD
Gatifloxacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.3e-05	0.000514	CcSEcCtD
Gatifloxacin—Palpitations—Losartan—type 2 diabetes mellitus	9.29e-05	0.000513	CcSEcCtD
Gatifloxacin—Nausea—Glimepiride—type 2 diabetes mellitus	9.26e-05	0.000512	CcSEcCtD
Gatifloxacin—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.24e-05	0.000511	CcSEcCtD
Gatifloxacin—Nausea—Sitagliptin—type 2 diabetes mellitus	9.23e-05	0.00051	CcSEcCtD
Gatifloxacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.23e-05	0.00051	CcSEcCtD
Gatifloxacin—Asthenia—Glyburide—type 2 diabetes mellitus	9.22e-05	0.00051	CcSEcCtD
Gatifloxacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.22e-05	0.00051	CcSEcCtD
Gatifloxacin—Anorexia—Metformin—type 2 diabetes mellitus	9.21e-05	0.000509	CcSEcCtD
Gatifloxacin—Urticaria—Gliclazide—type 2 diabetes mellitus	9.17e-05	0.000507	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—type 2 diabetes mellitus	9.16e-05	0.00207	CbGpPWpGaD
Gatifloxacin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.13e-05	0.000505	CcSEcCtD
Gatifloxacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.13e-05	0.000505	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.11e-05	0.000504	CcSEcCtD
Gatifloxacin—Oedema—Irbesartan—type 2 diabetes mellitus	9.11e-05	0.000504	CcSEcCtD
Gatifloxacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.11e-05	0.000504	CcSEcCtD
Gatifloxacin—Pruritus—Glyburide—type 2 diabetes mellitus	9.1e-05	0.000503	CcSEcCtD
Gatifloxacin—Constipation—Valsartan—type 2 diabetes mellitus	9.07e-05	0.000501	CcSEcCtD
Gatifloxacin—Infection—Irbesartan—type 2 diabetes mellitus	9.06e-05	0.000501	CcSEcCtD
Gatifloxacin—Hypotension—Metformin—type 2 diabetes mellitus	9.03e-05	0.000499	CcSEcCtD
Gatifloxacin—Erythema—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000498	CcSEcCtD
Gatifloxacin—Shock—Irbesartan—type 2 diabetes mellitus	8.97e-05	0.000496	CcSEcCtD
Gatifloxacin—Chest pain—Losartan—type 2 diabetes mellitus	8.95e-05	0.000495	CcSEcCtD
Gatifloxacin—Arthralgia—Losartan—type 2 diabetes mellitus	8.95e-05	0.000495	CcSEcCtD
Gatifloxacin—Myalgia—Losartan—type 2 diabetes mellitus	8.95e-05	0.000495	CcSEcCtD
Gatifloxacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.94e-05	0.000494	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.92e-05	0.000493	CcSEcCtD
Gatifloxacin—Anxiety—Losartan—type 2 diabetes mellitus	8.92e-05	0.000493	CcSEcCtD
Gatifloxacin—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.9e-05	0.000492	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	8.88e-05	0.002	CbGpPWpGaD
Gatifloxacin—Rash—Bromocriptine—type 2 diabetes mellitus	8.87e-05	0.00049	CcSEcCtD
Gatifloxacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.86e-05	0.00049	CcSEcCtD
Gatifloxacin—Tension—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000489	CcSEcCtD
Gatifloxacin—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.83e-05	0.000488	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000487	CcSEcCtD
Gatifloxacin—Headache—Bromocriptine—type 2 diabetes mellitus	8.81e-05	0.000487	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.8e-05	0.000486	CcSEcCtD
Gatifloxacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.8e-05	0.000486	CcSEcCtD
Gatifloxacin—Nervousness—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000484	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—NFKB1—type 2 diabetes mellitus	8.69e-05	0.00196	CbGpPWpGaD
Gatifloxacin—Anorexia—Irbesartan—type 2 diabetes mellitus	8.69e-05	0.00048	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.67e-05	0.000479	CcSEcCtD
Gatifloxacin—Paraesthesia—Metformin—type 2 diabetes mellitus	8.67e-05	0.000479	CcSEcCtD
Gatifloxacin—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000479	CcSEcCtD
Gatifloxacin—Confusional state—Losartan—type 2 diabetes mellitus	8.65e-05	0.000478	CcSEcCtD
Gatifloxacin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000477	CcSEcCtD
Gatifloxacin—Dyspnoea—Metformin—type 2 diabetes mellitus	8.61e-05	0.000476	CcSEcCtD
Gatifloxacin—Somnolence—Metformin—type 2 diabetes mellitus	8.59e-05	0.000475	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TRPC6—type 2 diabetes mellitus	8.58e-05	0.00194	CbGpPWpGaD
Gatifloxacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.58e-05	0.000474	CcSEcCtD
Gatifloxacin—Oedema—Losartan—type 2 diabetes mellitus	8.58e-05	0.000474	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.57e-05	0.000474	CcSEcCtD
Gatifloxacin—Infection—Losartan—type 2 diabetes mellitus	8.52e-05	0.000471	CcSEcCtD
Gatifloxacin—Hypotension—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000471	CcSEcCtD
Gatifloxacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.51e-05	0.00047	CcSEcCtD
Gatifloxacin—Dyspepsia—Metformin—type 2 diabetes mellitus	8.5e-05	0.00047	CcSEcCtD
Gatifloxacin—Tremor—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000467	CcSEcCtD
Gatifloxacin—Shock—Losartan—type 2 diabetes mellitus	8.44e-05	0.000467	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—IGF1—type 2 diabetes mellitus	8.43e-05	0.0019	CbGpPWpGaD
Gatifloxacin—Urticaria—Valsartan—type 2 diabetes mellitus	8.43e-05	0.000466	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.4e-05	0.000464	CcSEcCtD
Gatifloxacin—Decreased appetite—Metformin—type 2 diabetes mellitus	8.4e-05	0.000464	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—RELA—type 2 diabetes mellitus	8.39e-05	0.00189	CbGpPWpGaD
Gatifloxacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.38e-05	0.000464	CcSEcCtD
Gatifloxacin—Tachycardia—Losartan—type 2 diabetes mellitus	8.37e-05	0.000463	CcSEcCtD
Gatifloxacin—Nausea—Bromocriptine—type 2 diabetes mellitus	8.35e-05	0.000462	CcSEcCtD
Gatifloxacin—Urticaria—Orlistat—type 2 diabetes mellitus	8.33e-05	0.00046	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000459	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.29e-05	0.000458	CcSEcCtD
Gatifloxacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.28e-05	0.000458	CcSEcCtD
Gatifloxacin—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.28e-05	0.000458	CcSEcCtD
Gatifloxacin—Asthenia—Gliclazide—type 2 diabetes mellitus	8.28e-05	0.000458	CcSEcCtD
Gatifloxacin—Agitation—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000458	CcSEcCtD
Gatifloxacin—Constipation—Metformin—type 2 diabetes mellitus	8.26e-05	0.000457	CcSEcCtD
Gatifloxacin—Angioedema—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000455	CcSEcCtD
Gatifloxacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.18e-05	0.000452	CcSEcCtD
Gatifloxacin—Anorexia—Losartan—type 2 diabetes mellitus	8.18e-05	0.000452	CcSEcCtD
Gatifloxacin—Vomiting—Glyburide—type 2 diabetes mellitus	8.17e-05	0.000452	CcSEcCtD
Gatifloxacin—Pruritus—Gliclazide—type 2 diabetes mellitus	8.17e-05	0.000452	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	8.13e-05	0.00184	CbGpPWpGaD
Gatifloxacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.13e-05	0.000449	CcSEcCtD
Gatifloxacin—Rash—Glyburide—type 2 diabetes mellitus	8.11e-05	0.000448	CcSEcCtD
Gatifloxacin—Somnolence—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000448	CcSEcCtD
Gatifloxacin—Dermatitis—Glyburide—type 2 diabetes mellitus	8.1e-05	0.000448	CcSEcCtD
Gatifloxacin—Vertigo—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000448	CcSEcCtD
Gatifloxacin—Syncope—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000447	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	8.07e-05	0.00182	CbGpPWpGaD
Gatifloxacin—Headache—Glyburide—type 2 diabetes mellitus	8.05e-05	0.000445	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—type 2 diabetes mellitus	8.03e-05	0.00181	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.02e-05	0.000444	CcSEcCtD
Gatifloxacin—Hypotension—Losartan—type 2 diabetes mellitus	8.02e-05	0.000443	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—SERPINE1—type 2 diabetes mellitus	8e-05	0.00181	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	7.98e-05	0.0018	CbGpPWpGaD
Gatifloxacin—Palpitations—Ramipril—type 2 diabetes mellitus	7.96e-05	0.00044	CcSEcCtD
Gatifloxacin—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.96e-05	0.00044	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	7.94e-05	0.00179	CbGpPWpGaD
Gatifloxacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.92e-05	0.000438	CcSEcCtD
Gatifloxacin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000438	CcSEcCtD
Gatifloxacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.9e-05	0.000437	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.9e-05	0.000437	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.82e-05	0.000432	CcSEcCtD
Gatifloxacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.81e-05	0.000432	CcSEcCtD
Gatifloxacin—Convulsion—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000432	CcSEcCtD
Gatifloxacin—Constipation—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000431	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	7.77e-05	0.00175	CbGpPWpGaD
Gatifloxacin—Insomnia—Losartan—type 2 diabetes mellitus	7.76e-05	0.000429	CcSEcCtD
Gatifloxacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.72e-05	0.000427	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	7.71e-05	0.00174	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	7.71e-05	0.00174	CbGpPWpGaD
Gatifloxacin—Paraesthesia—Losartan—type 2 diabetes mellitus	7.7e-05	0.000426	CcSEcCtD
Gatifloxacin—Urticaria—Metformin—type 2 diabetes mellitus	7.67e-05	0.000424	CcSEcCtD
Gatifloxacin—Arthralgia—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000424	CcSEcCtD
Gatifloxacin—Myalgia—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000424	CcSEcCtD
Gatifloxacin—Chest pain—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000424	CcSEcCtD
Gatifloxacin—Dyspnoea—Losartan—type 2 diabetes mellitus	7.65e-05	0.000423	CcSEcCtD
Gatifloxacin—Anxiety—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000423	CcSEcCtD
Gatifloxacin—Nausea—Glyburide—type 2 diabetes mellitus	7.64e-05	0.000422	CcSEcCtD
Gatifloxacin—Abdominal pain—Metformin—type 2 diabetes mellitus	7.64e-05	0.000422	CcSEcCtD
Gatifloxacin—Dizziness—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.000422	CcSEcCtD
Gatifloxacin—Somnolence—Losartan—type 2 diabetes mellitus	7.63e-05	0.000422	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—type 2 diabetes mellitus	7.62e-05	0.00172	CbGpPWpGaD
Gatifloxacin—Asthenia—Valsartan—type 2 diabetes mellitus	7.61e-05	0.000421	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	7.58e-05	0.00171	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—ADRA2A—type 2 diabetes mellitus	7.55e-05	0.00171	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Losartan—type 2 diabetes mellitus	7.55e-05	0.000417	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TIMP1—type 2 diabetes mellitus	7.52e-05	0.0017	CbGpPWpGaD
Gatifloxacin—Asthenia—Orlistat—type 2 diabetes mellitus	7.52e-05	0.000416	CcSEcCtD
Gatifloxacin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000415	CcSEcCtD
Gatifloxacin—Pruritus—Valsartan—type 2 diabetes mellitus	7.5e-05	0.000415	CcSEcCtD
Gatifloxacin—Decreased appetite—Losartan—type 2 diabetes mellitus	7.46e-05	0.000412	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000412	CcSEcCtD
Gatifloxacin—Confusional state—Ramipril—type 2 diabetes mellitus	7.42e-05	0.00041	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	7.42e-05	0.00167	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	7.42e-05	0.00167	CbGpPWpGaD
Gatifloxacin—Pruritus—Orlistat—type 2 diabetes mellitus	7.41e-05	0.00041	CcSEcCtD
Gatifloxacin—Oedema—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000407	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000407	CcSEcCtD
Gatifloxacin—Vomiting—Gliclazide—type 2 diabetes mellitus	7.34e-05	0.000406	CcSEcCtD
Gatifloxacin—Constipation—Losartan—type 2 diabetes mellitus	7.34e-05	0.000406	CcSEcCtD
Gatifloxacin—Rash—Gliclazide—type 2 diabetes mellitus	7.28e-05	0.000402	CcSEcCtD
Gatifloxacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.27e-05	0.000402	CcSEcCtD
Gatifloxacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.26e-05	0.000401	CcSEcCtD
Gatifloxacin—Urticaria—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.0004	CcSEcCtD
Gatifloxacin—Shock—Ramipril—type 2 diabetes mellitus	7.24e-05	0.0004	CcSEcCtD
Gatifloxacin—Headache—Gliclazide—type 2 diabetes mellitus	7.23e-05	0.0004	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	7.23e-05	0.00163	CbGpPWpGaD
Gatifloxacin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000398	CcSEcCtD
Gatifloxacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000398	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000398	CcSEcCtD
Gatifloxacin—Tachycardia—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000397	CcSEcCtD
Gatifloxacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.17e-05	0.000396	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000393	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—NFKB1—type 2 diabetes mellitus	7.07e-05	0.0016	CbGpPWpGaD
Gatifloxacin—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.07e-05	0.000391	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.05e-05	0.00159	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.01e-05	0.000388	CcSEcCtD
Gatifloxacin—Dizziness—Valsartan—type 2 diabetes mellitus	7.01e-05	0.000388	CcSEcCtD
Gatifloxacin—Anorexia—Ramipril—type 2 diabetes mellitus	7.01e-05	0.000388	CcSEcCtD
Gatifloxacin—Dizziness—Orlistat—type 2 diabetes mellitus	6.93e-05	0.000383	CcSEcCtD
Gatifloxacin—Asthenia—Metformin—type 2 diabetes mellitus	6.93e-05	0.000383	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	6.89e-05	0.00156	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	6.89e-05	0.00156	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	6.89e-05	0.00156	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PTPN1—type 2 diabetes mellitus	6.88e-05	0.00155	CbGpPWpGaD
Gatifloxacin—Hypotension—Ramipril—type 2 diabetes mellitus	6.87e-05	0.00038	CcSEcCtD
Gatifloxacin—Nausea—Gliclazide—type 2 diabetes mellitus	6.86e-05	0.000379	CcSEcCtD
Gatifloxacin—Pruritus—Metformin—type 2 diabetes mellitus	6.83e-05	0.000378	CcSEcCtD
Gatifloxacin—Urticaria—Losartan—type 2 diabetes mellitus	6.81e-05	0.000377	CcSEcCtD
Gatifloxacin—Abdominal pain—Losartan—type 2 diabetes mellitus	6.78e-05	0.000375	CcSEcCtD
Gatifloxacin—Body temperature increased—Losartan—type 2 diabetes mellitus	6.78e-05	0.000375	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	6.77e-05	0.00153	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	6.76e-05	0.00153	CbGpPWpGaD
Gatifloxacin—Vomiting—Valsartan—type 2 diabetes mellitus	6.74e-05	0.000373	CcSEcCtD
Gatifloxacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.000371	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.7e-05	0.00037	CcSEcCtD
Gatifloxacin—Rash—Valsartan—type 2 diabetes mellitus	6.69e-05	0.00037	CcSEcCtD
Gatifloxacin—Dermatitis—Valsartan—type 2 diabetes mellitus	6.68e-05	0.000369	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	6.66e-05	0.00151	CbGpPWpGaD
Gatifloxacin—Vomiting—Orlistat—type 2 diabetes mellitus	6.66e-05	0.000368	CcSEcCtD
Gatifloxacin—Insomnia—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000368	CcSEcCtD
Gatifloxacin—Headache—Valsartan—type 2 diabetes mellitus	6.64e-05	0.000367	CcSEcCtD
Gatifloxacin—Diarrhoea—Metformin—type 2 diabetes mellitus	6.61e-05	0.000365	CcSEcCtD
Gatifloxacin—Rash—Orlistat—type 2 diabetes mellitus	6.61e-05	0.000365	CcSEcCtD
Gatifloxacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000365	CcSEcCtD
Gatifloxacin—Dermatitis—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000365	CcSEcCtD
Gatifloxacin—Headache—Orlistat—type 2 diabetes mellitus	6.57e-05	0.000363	CcSEcCtD
Gatifloxacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000363	CcSEcCtD
Gatifloxacin—Asthenia—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000362	CcSEcCtD
Gatifloxacin—Somnolence—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000361	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	6.48e-05	0.00146	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000358	CcSEcCtD
Gatifloxacin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000357	CcSEcCtD
Gatifloxacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000353	CcSEcCtD
Gatifloxacin—Dizziness—Metformin—type 2 diabetes mellitus	6.39e-05	0.000353	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ATP2A3—type 2 diabetes mellitus	6.35e-05	0.00143	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.32e-05	0.000349	CcSEcCtD
Gatifloxacin—Nausea—Valsartan—type 2 diabetes mellitus	6.3e-05	0.000348	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.3e-05	0.00142	CbGpPWpGaD
Gatifloxacin—Constipation—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000348	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.28e-05	0.00142	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.28e-05	0.00142	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	6.25e-05	0.00141	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000345	CcSEcCtD
Gatifloxacin—Nausea—Orlistat—type 2 diabetes mellitus	6.23e-05	0.000344	CcSEcCtD
Gatifloxacin—Asthenia—Losartan—type 2 diabetes mellitus	6.15e-05	0.00034	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	6.14e-05	0.00139	CbGpPWpGaD
Gatifloxacin—Vomiting—Metformin—type 2 diabetes mellitus	6.14e-05	0.000339	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	6.13e-05	0.00138	CbGpPWpGaD
Gatifloxacin—Rash—Metformin—type 2 diabetes mellitus	6.09e-05	0.000337	CcSEcCtD
Gatifloxacin—Dermatitis—Metformin—type 2 diabetes mellitus	6.08e-05	0.000336	CcSEcCtD
Gatifloxacin—Pruritus—Losartan—type 2 diabetes mellitus	6.07e-05	0.000336	CcSEcCtD
Gatifloxacin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000335	CcSEcCtD
Gatifloxacin—Headache—Metformin—type 2 diabetes mellitus	6.05e-05	0.000335	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.05e-05	0.00137	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.05e-05	0.00137	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.04e-05	0.00136	CbGpPWpGaD
Gatifloxacin—Dizziness—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000333	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000333	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.94e-05	0.00134	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	5.93e-05	0.00134	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Losartan—type 2 diabetes mellitus	5.87e-05	0.000324	CcSEcCtD
Gatifloxacin—Urticaria—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000323	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	5.82e-05	0.00131	CbGpPWpGaD
Gatifloxacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000321	CcSEcCtD
Gatifloxacin—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000321	CcSEcCtD
Gatifloxacin—Vomiting—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.00032	CcSEcCtD
Gatifloxacin—Rash—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000318	CcSEcCtD
Gatifloxacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000317	CcSEcCtD
Gatifloxacin—Nausea—Metformin—type 2 diabetes mellitus	5.74e-05	0.000317	CcSEcCtD
Gatifloxacin—Headache—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000316	CcSEcCtD
Gatifloxacin—Dizziness—Losartan—type 2 diabetes mellitus	5.67e-05	0.000314	CcSEcCtD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	5.67e-05	0.00128	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	5.62e-05	0.00127	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	5.5e-05	0.00124	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	5.5e-05	0.00124	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.49e-05	0.00124	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	5.46e-05	0.00123	CbGpPWpGaD
Gatifloxacin—Vomiting—Losartan—type 2 diabetes mellitus	5.45e-05	0.000302	CcSEcCtD
Gatifloxacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.42e-05	0.0003	CcSEcCtD
Gatifloxacin—Nausea—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000299	CcSEcCtD
Gatifloxacin—Rash—Losartan—type 2 diabetes mellitus	5.41e-05	0.000299	CcSEcCtD
Gatifloxacin—Dermatitis—Losartan—type 2 diabetes mellitus	5.4e-05	0.000299	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—THBD—type 2 diabetes mellitus	5.4e-05	0.00122	CbGpPWpGaD
Gatifloxacin—Headache—Losartan—type 2 diabetes mellitus	5.37e-05	0.000297	CcSEcCtD
Gatifloxacin—Asthenia—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000292	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	5.24e-05	0.00118	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.22e-05	0.00118	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.22e-05	0.00118	CbGpPWpGaD
Gatifloxacin—Pruritus—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000288	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.14e-05	0.00116	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.14e-05	0.00116	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	5.13e-05	0.00116	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—BHMT—type 2 diabetes mellitus	5.12e-05	0.00116	CbGpPWpGaD
Gatifloxacin—Nausea—Losartan—type 2 diabetes mellitus	5.1e-05	0.000282	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	5.05e-05	0.00114	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000278	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.97e-05	0.00112	CbGpPWpGaD
Gatifloxacin—Dizziness—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000269	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	4.81e-05	0.00109	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.76e-05	0.00108	CbGpPWpGaD
Gatifloxacin—Vomiting—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000259	CcSEcCtD
Gatifloxacin—Rash—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000256	CcSEcCtD
Gatifloxacin—Dermatitis—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000256	CcSEcCtD
Gatifloxacin—Headache—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000255	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	4.56e-05	0.00103	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	4.54e-05	0.00103	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	4.48e-05	0.00101	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AANAT—type 2 diabetes mellitus	4.48e-05	0.00101	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	4.47e-05	0.00101	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	4.44e-05	0.001	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	4.42e-05	0.000999	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	4.37e-05	0.000987	CbGpPWpGaD
Gatifloxacin—Nausea—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000242	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—F7—type 2 diabetes mellitus	4.35e-05	0.000982	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	4.27e-05	0.000964	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.26e-05	0.000962	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CDO1—type 2 diabetes mellitus	4.25e-05	0.000959	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPD2—type 2 diabetes mellitus	4.25e-05	0.000959	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.15e-05	0.000937	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.13e-05	0.000934	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.12e-05	0.000932	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AK1—type 2 diabetes mellitus	4.05e-05	0.000915	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4e-05	0.000904	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.95e-05	0.000891	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.95e-05	0.000891	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	3.89e-05	0.000879	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	3.88e-05	0.000875	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	3.88e-05	0.000875	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.85e-05	0.00087	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.83e-05	0.000865	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.81e-05	0.00086	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	3.74e-05	0.000844	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	3.74e-05	0.000844	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	3.74e-05	0.000844	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	3.74e-05	0.000844	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.72e-05	0.000841	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.65e-05	0.000825	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	3.64e-05	0.000823	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.62e-05	0.000818	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HBA2—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—G6PC—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ND1—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	3.61e-05	0.000815	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	3.55e-05	0.000802	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	3.55e-05	0.000801	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	3.53e-05	0.000797	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GCGR—type 2 diabetes mellitus	3.5e-05	0.00079	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	3.49e-05	0.000788	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	3.39e-05	0.000765	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.37e-05	0.00076	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.36e-05	0.000758	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	3.3e-05	0.000746	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYTB—type 2 diabetes mellitus	3.3e-05	0.000746	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	3.22e-05	0.000727	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.2e-05	0.000723	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	3.16e-05	0.000714	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—STAR—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ACACA—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.07e-05	0.000693	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	3.06e-05	0.00069	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	3e-05	0.000678	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CBS—type 2 diabetes mellitus	2.94e-05	0.000665	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	2.94e-05	0.000665	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—APOB—type 2 diabetes mellitus	2.91e-05	0.000658	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	2.83e-05	0.00064	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—COX2—type 2 diabetes mellitus	2.83e-05	0.00064	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	2.78e-05	0.000629	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.78e-05	0.000628	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UCP2—type 2 diabetes mellitus	2.74e-05	0.000618	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	2.74e-05	0.000618	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UCP3—type 2 diabetes mellitus	2.74e-05	0.000618	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.65e-05	0.000599	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.65e-05	0.000597	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CD36—type 2 diabetes mellitus	2.64e-05	0.000597	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.63e-05	0.000595	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	2.61e-05	0.00059	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.61e-05	0.000589	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PCK1—type 2 diabetes mellitus	2.57e-05	0.000581	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.53e-05	0.000572	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.52e-05	0.00057	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	2.51e-05	0.000566	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.47e-05	0.000558	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	2.44e-05	0.000551	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	2.41e-05	0.000544	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HK1—type 2 diabetes mellitus	2.41e-05	0.000544	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.41e-05	0.000543	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.36e-05	0.000532	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	2.34e-05	0.000529	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GCKR—type 2 diabetes mellitus	2.33e-05	0.000525	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LPA—type 2 diabetes mellitus	2.33e-05	0.000525	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	2.33e-05	0.000525	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	2.33e-05	0.000525	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	2.31e-05	0.000521	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	2.24e-05	0.000506	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.24e-05	0.000505	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	2.23e-05	0.000504	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	2.2e-05	0.000497	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	2.17e-05	0.000491	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.17e-05	0.000489	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.13e-05	0.00048	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.12e-05	0.000479	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.1e-05	0.000474	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	2.07e-05	0.000468	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2e-05	0.000451	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	1.94e-05	0.000437	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	1.93e-05	0.000435	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	1.93e-05	0.000435	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	1.9e-05	0.000428	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTR—type 2 diabetes mellitus	1.9e-05	0.000428	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.86e-05	0.00042	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.85e-05	0.000418	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.85e-05	0.000417	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.85e-05	0.000417	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.85e-05	0.000417	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.84e-05	0.000415	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.83e-05	0.000413	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.8e-05	0.000407	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.78e-05	0.000403	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.75e-05	0.000395	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.75e-05	0.000395	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.66e-05	0.000374	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.66e-05	0.000374	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.66e-05	0.000374	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.63e-05	0.000368	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1.61e-05	0.000364	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.59e-05	0.000359	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.58e-05	0.000356	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.56e-05	0.000352	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.52e-05	0.000342	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.5e-05	0.000339	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.5e-05	0.000339	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.46e-05	0.00033	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.45e-05	0.000329	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.44e-05	0.000325	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.44e-05	0.000325	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SRC—type 2 diabetes mellitus	1.29e-05	0.000292	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.26e-05	0.000284	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.24e-05	0.00028	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.24e-05	0.00028	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.23e-05	0.000279	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.22e-05	0.000275	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOB—type 2 diabetes mellitus	1.18e-05	0.000267	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	1.16e-05	0.000261	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	1.15e-05	0.00026	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LPL—type 2 diabetes mellitus	1.13e-05	0.000255	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	1.1e-05	0.000249	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX1—type 2 diabetes mellitus	1.1e-05	0.000249	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CD36—type 2 diabetes mellitus	1.07e-05	0.000242	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.06e-05	0.000239	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.02e-05	0.000229	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARA—type 2 diabetes mellitus	9.96e-06	0.000225	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AGT—type 2 diabetes mellitus	9.65e-06	0.000218	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CALM1—type 2 diabetes mellitus	9.49e-06	0.000214	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOE—type 2 diabetes mellitus	9.45e-06	0.000214	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOA1—type 2 diabetes mellitus	9.35e-06	0.000211	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARG—type 2 diabetes mellitus	8.24e-06	0.000186	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—INS—type 2 diabetes mellitus	8.08e-06	0.000182	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	8.03e-06	0.000181	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	7.08e-06	0.00016	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NOS3—type 2 diabetes mellitus	7.08e-06	0.00016	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	6.48e-06	0.000146	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKT1—type 2 diabetes mellitus	3.26e-06	7.35e-05	CbGpPWpGaD
